Life Sciences

Helping clients outperform and innovate across the life sciences industries

How we help clients

Medtech

Bringing cutting edge capabilities in design, digital and analytics to create innovative products, devices, equipment, software, and solutions that enhance patient value and outcomes.

Generics

Helping companies capture opportunities across the value chain for generics, branded generics, established products and biosimilars, and forging connections among industry stakeholders.

Medical Affairs

Helping clients to transform their medical affairs function into the company’s third strategic pillar alongside R&D and commercial.

Operations

Using our operations expertise to drive performance, increase revenue, and enhance the bottom line.

Research & Development

Helping clients build the R&D capabilities needed to drive innovation, improve productivity and performance, and develop successful portfolio and asset strategies.

Commercial

Helping clients maximize commercial value by assisting with product launch, marketing, sales, and market access.

How we make a difference

McKinsey Cancer Center

The McKinsey Cancer Center helps life sciences organizations discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer.

Our people

Jake Henry

Senior Partner, Chicago
Leads McKinsey’s global work in medtech, and serves leading medical technology companies as they set strategy, pursue growth opportunities, and...

Chris Llewellyn

Senior Partner, London
Leads our work globally in the life sciences, biopharma, medical products and health technology spaces

Axel Baur

Senior Partner, Hong Kong
Supports healthcare companies to develop global strategies and operating models

Featured capability

POBOS

POBOS provides information on cost, productivity and quality, supply chain performance, and quality performance across more than 35 pharmaceutical and biotech companies. Companies can use the information to understand productivity drivers and their impact and quickly focus efforts on the highest value areas.

Featured insight

Article

Precision medicine in practice: Strategies for rare cancers

– The small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions,... but rare cancers face extra barriers to widespread treatment.
Article

Winning against COVID-19: The implications for biopharma

– How companies act individually and collectively in the next few weeks and months will shape the outcome of the pandemic and the... reputation of the biopharma industry for decades to come.
Article

The promise of digital therapeutics

– Investments in digital-therapeutics companies in the United States have grown, on average, by 40 percent a year over the past... seven years. What lies ahead for this fast-moving sector?

Connect with our Life Sciences Practice